|
|
SFX by Ex Libris Inc.
|
List of services to meet your request
|
|||||||||||||||
|
|||||||||||||||
© 2024 SFX by Ex Libris Inc. | Cookie Policy
CrossRef Omogočeno
![](https://beacon01.alma.exlibrisgroup.com/boom/apache_pb.gif?SRVR=adz.izum.si&IP=193.2.126.232&A=SFX&P=SFXMenu&S=s153A3B2A-337C-11EF-B920-C62285CE164B&I=39IZM&T=&OP=Display&O=html&O1=12616362&O2=954925241048&O3=&O4=summon.serialssolutions.com&O5=https%3A%2F%2Fadz.izum.si%2Fsfxlcl41%3Fctx_enc%3Dinfo%253Aofi%252Fenc%253AUTF-8%26ctx_ver%3DZ39.88-2004%26rfr_id%3Dinfo%253Asid%252Fsummon.serialssolutions.com%26rft.atitle%3DA%2520case%2520of%2520under-dosing%2520after%2520raltegravir%2520formulation%2520change%2520in%2520an%2520elderly%2520patient%2520treated%2520for%2520HIV%26rft.au%3DHigashino%252C%2520S%26rft.au%3DKobayashi%252C%2520S%26rft.au%3DMomo%252C%2520K%26rft.au%3DYasu%252C%2520T%26rft.date%3D2019-01-01%26rft.epage%3D63%26rft.externalDBID%3DNO_FULL_TEXT%26rft.genre%3Darticle%26rft.issn%3D0031-7144%26rft.issue%3D1%26rft.jtitle%3DPharmazie%26rft.spage%3D62%26rft.volume%3D74%26rft_id%3Dinfo%253Adoi%252F10.1691%252Fph.2019.8788%26rft_val_fmt%3Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal&O6=1-EZB-FREE-00999_FREELY_AVAILABLE_EZB_JOURNALS-getFullTxt-object,2-COBIB_SI_LCL-getHolding-object,3-DOI-getDOI-object,4-ELSEVIER_SCOPUS_FIS_LCL-getAbstract-object,5-NCBI_PUBMED_FREE-getAbstract-object,6-ISI_WEB_OF_SCIENCE-getAuthor-object,7-ISI_JOURNAL_CITATION_REPORTS_SCIENCE_EDITION-getCitedJournal-object,8-REFWORKS_EXPORT_TOOL-getReference-object,9-GOOGLE_SCHOLAR_FREE-getWebSearch-object,10-WWW_SEARCH_ENGINES_FREE-getWebSearch-object&O7=0.769596&O8=N&O9=<ctx:context-object identifier="urn:sfxstat:12616362-s153A3B2A-337C-11EF-B920-C62285CE164B" timestamp="2024-06-26T07:22:30Z" xmlns:ctx="info:ofi/fmt:xml:xsd:ctx">
<ctx:referent>
<ctx:identifier>urn:sfxid:954925241048</ctx:identifier>
<ctx:metadata-by-val>
<ctx:format>info:ofi/fmt:xml:xsd:journal</ctx:format>
<ctx:metadata>
<jnl:journal xmlns:jnl="info:ofi/fmt:xml:xsd:journal">
<jnl:atitle>A case of under-dosing after raltegravir formulation change in an elderly patient treated for HIV</jnl:atitle>
<jnl:jtitle>Pharmazie</jnl:jtitle>
<jnl:date>2019-01-01</jnl:date>
<jnl:spage>62</jnl:spage>
<jnl:epage>63</jnl:epage>
<jnl:coden>PHARAT</jnl:coden>
<jnl:issn>0031-7144</jnl:issn>
<jnl:volume>74</jnl:volume>
<jnl:issue>1</jnl:issue>
<jnl:genre>article</jnl:genre>
<jnl:language>ger</jnl:language>
<jnl:coden>PHARAT</jnl:coden>
<jnl:authors></jnl:authors>
</jnl:journal>
</ctx:metadata>
</ctx:metadata-by-val>
</ctx:referent>
<ctx:requester>
<ctx:identifier>urn:ip:1e13ef44534c02c1ad1c27dd68a724b3d27c642b</ctx:identifier>
<ctx:identifier>urn:UUID:s153A3B2A-337C-11EF-B920-C62285CE164B</ctx:identifier>
</ctx:requester>
<ctx:referrer>
<ctx:identifier>info:sid/summon.serialssolutions.com</ctx:identifier>
</ctx:referrer>
<ctx:service-type>
<ctx:metadata-by-val>
<ctx:format>info:ofi/fmt:xml:xsd:svcList</ctx:format>
<ctx:metadata>
<svc:svcList xmlns:svc="http://www.exlibrisgroup.com/schema/info:ofi/fmt:xml:xsd:sch_svc"></svc:svcList>
</ctx:metadata>
</ctx:metadata-by-val>
</ctx:service-type>
<ctx:resolver>
<ctx:identifier>https://adz.izum.si/sfxlcl41</ctx:identifier>
</ctx:resolver>
</ctx:context-object>
&)